
Cell and Gene Therapy market is set to grow multifold by 2030, Leverage Circulants CG2 to manage complexity and gain competitive advantage.
We deliver large Pharma companies with a robust digital backbone built on Salesforce Service Cloud and Experience Cloud. CG2 bridges the gap between the clinical site and the manufacturing floor, ensuring that the Chain of Identity (CoI) and Chain of Custody (CoC) remain unbroken.
.png)
Circulants CG2 is built with AI embedded Architecture where artificial intelligence acts as the central intelligence layer connecting clinical, genomic, and manufacturing data to therapy development and delivery. AI capabilities enable key outcomes such as patient stratification, treatment personalization, cell engineering optimization, and manufacturing process monitoring with quality control. The architecture also includes an AI insights dashboard for real-time decision support, supported by data security, compliance frameworks, and continuous learning loops, allowing AI models to improve over time and optimize both clinical outcomes and biomanufacturing efficiency.
Download Fact SheetIn large and globally spread pharma organizations, it is imperative to have a Data ecosystem that integrates best-of-breed, multi-vendor tools to build flexible data platforms serving subject matter experts, frontline sales team, data scientists, and developers. We deliver modern data engineering services in partnership with industry leaders help in modernizing your data ecosystem and be AI ready.
A unified command center for the entire therapy lifecycle.
Leveraging Salesforce Experience Cloud
Direct Courier Integration (e.g., Biocair)
Leveraging Salesforce Service Cloud
Overcome Clinical operations pAIn to gAIn strategic advantage using our AI enabled solution accelerators to automate clinical workflows.
Empower your clinical sites, optimize your supply chain, and ensure every patient receives their therapy on time, every time.
Book a Demo Now